Romain Banchereau

11PUBLICATIONS
108CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersInnate immunitySystems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 05, 2026
The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1-Resistant Cancer.

Juliette Roels, Hamid Ghaedi, Jayaram Kancherla

|Feb 26, 2026
A Tumor-Promoting Inflammatory SPP1+ Macrophage-IL6-CRP Axis Drives Immune Dysfunction in Bladder Cancer.

Michelle A Tran, Byuri Angela Cho, Sudeh Izadmehr

|Sep 02, 2025
Intron retention regulates STAT2 function and predicts immunotherapy response in lung cancer.

Ryan P Englander, Mattia Brugiolo, Te-Chia Wu

|Jan 24, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.

Matthew D Galsky, Mark Kockx, Juliette Roels

|Sep 28, 2022
LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity.

Akshay T Krishnamurty, Justin A Shyer, Minh Thai

|Jul 25, 2022
Clinico-Genomic Characterization of Patients with Metastatic Urothelial Carcinoma in Real-World Practice Identifies a Novel Bladder Immune Performance Index (BIPI).

Bernadett Szabados, Mariano Ponz-Sarvisé, Robson Machado

Pageof 2